Skip to main content
. 2017 Dec 4;12:3449–3456. doi: 10.2147/COPD.S143967

Figure 3.

Figure 3

Rates of roflumilast adverse events by BMI group.

Notes: In the underweight and normal BMI groups, the roflumilast adverse events rates were 41.4% and 45.3%, respectively. On the other hand, in the overweight and obese BMI groups, the roflumilast adverse events rates were 27.5% and 14.3%, respectively.

Abbreviation: BMI, body mass index.